In the STEP2 focusing on 1,210 patients with obesity or overweight and T2D, average weight loss with semaglutide 2.4 mg therapy was 6.2% compared to the placebo [47]
Clinical trials involving the active ingredients in these medications have shown remarkable results
The mechanism is likely related to the metabolic changes, reduced caloric intake combined with the body adjusting to higher drug levels
In a double-blind, placebo-controlled, phase 2b trial, patients with diabetes were administered all doses of tirzepatide, dulaglutide, or placebo
If you are a beginner, start with full-body sessions twice per week and progress one rep or 5 lb per week per movement
Because exosomes and many peptides are pro-growth, they can be risky in active cancer or where malignancy is suspected